BI
BVF Inc’s Ovid Therapeutics OVID Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.27M | Hold |
3,853,818
| – | – | 0.05% | 42 |
|
2025
Q1 | $1.2M | Hold |
3,853,818
| – | – | 0.05% | 49 |
|
2024
Q4 | $3.6M | Hold |
3,853,818
| – | – | 0.12% | 45 |
|
2024
Q3 | $4.55M | Hold |
3,853,818
| – | – | 0.13% | 43 |
|
2024
Q2 | $2.96M | Hold |
3,853,818
| – | – | 0.08% | 48 |
|
2024
Q1 | $11.8M | Sell |
3,853,818
-2,997,233
| -44% | -$9.14M | 0.32% | 38 |
|
2023
Q4 | $22.1M | Hold |
6,851,051
| – | – | 0.55% | 37 |
|
2023
Q3 | $26.3M | Hold |
6,851,051
| – | – | 0.71% | 31 |
|
2023
Q2 | $22.5M | Hold |
6,851,051
| – | – | 0.63% | 32 |
|
2023
Q1 | $17.7M | Hold |
6,851,051
| – | – | 0.65% | 42 |
|
2022
Q4 | $12.7M | Hold |
6,851,051
| – | – | 0.54% | 46 |
|
2022
Q3 | $12.6M | Hold |
6,851,051
| – | – | 0.52% | 49 |
|
2022
Q2 | $14.7M | Hold |
6,851,051
| – | – | 0.71% | 39 |
|
2022
Q1 | $21.5M | Buy |
6,851,051
+220,000
| +3% | +$691K | 0.86% | 34 |
|
2021
Q4 | $21.3M | Hold |
6,631,051
| – | – | 0.77% | 38 |
|
2021
Q3 | $22.3M | Hold |
6,631,051
| – | – | 0.87% | 32 |
|
2021
Q2 | $25.9M | Buy |
6,631,051
+213,500
| +3% | +$835K | 0.97% | 26 |
|
2021
Q1 | $25.8M | Buy |
6,417,551
+1,895,500
| +42% | +$7.62M | 0.97% | 29 |
|
2020
Q4 | $10.4M | Buy |
4,522,051
+900,000
| +25% | +$2.08M | 0.41% | 44 |
|
2020
Q3 | $20.8M | Buy |
3,622,051
+1,229,900
| +51% | +$7.06M | 1.13% | 30 |
|
2020
Q2 | $17.6M | Buy |
2,392,151
+1,106,147
| +86% | +$8.15M | 1.09% | 28 |
|
2020
Q1 | $3.83M | Buy |
1,286,004
+551,703
| +75% | +$1.64M | 0.36% | 43 |
|
2019
Q4 | $3.05M | Sell |
734,301
-1,586,935
| -68% | -$6.59M | 0.23% | 48 |
|
2019
Q3 | $7.52M | Sell |
2,321,236
-1,262,000
| -35% | -$4.09M | 0.79% | 37 |
|
2019
Q2 | $6.63M | Buy |
3,583,236
+290,236
| +9% | +$537K | 0.72% | 38 |
|
2019
Q1 | $5.83M | Buy |
+3,293,000
| New | +$5.83M | 0.65% | 41 |
|